Factdock Insights

Likitanci da magunguna

Likitancin ɗan adam: amincewa, sanarwar tsaro da gwaje-gwaje da sanarwar kamfanoni da ke bayansu.

Raba
An sabunta · 2026-11-05 22:10 UTC38
Jerin manyan kalmomin da ake tattaunawa a duniyaDuba cikakken jerin dukkan fannoniRufe

Batutuwan da mutane a duk faɗin duniya ke karantawa mafi yawa a Wikipedia a yanzu, bisa ga fanni. Ana sabuntawa kowace rana.

Jerin duniya: ana haɗa kallon shafuka daga dukkan bugun harsuna na Wikipedia kowace rana. Manyan 5 a kowane fanni.

Kallon shafukan Wikipedia · 5 Nuw, 2026

Likitanci da magungunaMasu hauhawa a yau
  1. Selective mutismKallo: 12.4D+1,438%Sabo
  2. OpisthorchiasisKallo: 2.4K+1,978%Sabo
  3. MiliumKallo: 1.3K+628%Sabo
  4. May–Thurner syndromeKallo: 1.9K+362%
  5. ChordomaKallo: 973+402%
Lafiyar dabbobiMasu hauhawa a yau
  1. MedetomidineKallo: 1.7K+1,066%Sabo
  2. Equine atypical myopathyKallo: 235+488%
  3. MpoxKallo: 966+40%Sabo
  4. ChikungunyaKallo: 1K+35%
  5. EchinococcosisKallo: 634+34%
Tsaron abinci da nomaMasu hauhawa a yau
  1. 堺市学童集団下痢症Kallo: 155+58%Sabo
  2. Inosinic acidKallo: 112+44%Sabo
  3. Flavin mononucleotideKallo: 104+53%Sabo
  4. OrceinKallo: 60+82%Sabo
  5. ソテツ地獄Kallo: 63+31%
Kimiyya da fasahaMasu hauhawa a yau
  1. Superfluid helium-4Kallo: 923+739%
  2. Neil Gehrels Swift ObservatoryKallo: 6.6K+337%
  3. Mars Orbiter MissionKallo: 1.1K+387%
  4. Swift boost missionKallo: 767+341%
  5. K2-155dKallo: 374+713%
Tsaron yanar gizo da ƙa'idojin bayanaiMasu hauhawa a yau
  1. Noname057(16)Kallo: 859+399%
  2. БуткитKallo: 141+1,914%Sabo
  3. Anonymous (hacker group)Kallo: 3.1K+36%Sabo
  4. Cutar KwamfutaKallo: 1.4K+31%Sabo
  5. SpamouflageKallo: 218+132%
Makamashi da yanayiMasu hauhawa a yau
  1. Ruwan ruwa na KaribaKallo: 598+286%Sabo
  2. Amager BakkeKallo: 750+233%
  3. Malampaya gas fieldKallo: 278+827%Sabo
  4. Grand Coulee DamKallo: 860+178%Sabo
  5. Sakhalin-IIKallo: 365+335%Sabo
Mallakar hankali da haƙƙin ƙirƙiraMafi yawan kallo a yau
  1. Benz Patent-MotorwagenKallo: 943
  2. Digital Millennium Copyright ActKallo: 456+16%
  3. World Intellectual Property OrganizationKallo: 374+20%
  4. Berne ConventionKallo: 188
  5. United States Patent and Trademark OfficeKallo: 161+16%
Kasuwanci da sarkar samarwaMasu hauhawa a yau
  1. Tariffs in the second Trump administrationKallo: 1.3K+77%
  2. 2025–2026 Canada–United States trade warKallo: 483+89%
  3. North American Free Trade AgreementKallo: 998+31%
  4. China–United States trade warKallo: 745+30%
  5. Chicken TaxKallo: 235+94%Sabo
Sanarwar kamfanoni da haɗin gwiwaMasu hauhawa a yau
  1. Central Bank of ParaguayKallo: 2.5K+1,622%
  2. David Jones (department store)Kallo: 15.3D+739%
  3. KNDSKallo: 3.3K+824%Sabo
  4. Japan TobaccoKallo: 4.7K+705%Sabo
  5. Crane Co.Kallo: 916+1,105%Sabo

Mambobi za su iya ganin manyan 30, yanayin mako-mako da jerin matsayi na kowane harshe.

An jera su ne bisa yawan kallon shafukan Wikipedia daga masu karatu na ɗan Adam. Yawan kallo yana nuna yawan hankalin da ake bai wa batu, ba muhimmancinsa ko sahihancinsa ba. Tushe: Wikimedia Foundation (CC0).

Babban labarin yau

Amphastar Pharmaceuticals Ta Bayyana Sakamakon Kuɗi na Watanni Uku da Suka Ƙare a Ranar 30 ga Satumba, 2026

Jimillar kudaden shiga sun kai dala miliyan 207.6 na watanni uku da suka kare a ranar 30 ga Satumba, 2026. Babban ribar GAAP ta kai dala miliyan 37.8, ko dala 0.87 a kowane hannun jari, don kwata na uku. An daidaita ribar da ba ta GAAP ba ta kai dala miliyan 49.3, ko dala 1.14 a kowane hannun jari, don kwata na uku. Kamfanin zai gudanar da taron tattaunawa a yau da karfe 2:00...

Likitanci da magungunaAyyukan da ake kan yi da ci gabaPR Newswire (Health)
Karanta tushen
Likitanci da magungunaAyyukan da ake kan yi da ci gabaPR Newswire (Health)

Enliven Therapeutics Ta Bayyana Sakamakon Kuɗi na Kwata na Uku na 2026 Sannan Ta Kuma Bayar da Sabuntawar Kasuwanci

Sun cimma matsaya da Hukumar Abinci da Magunguna ta Amurka (FDA) kan tsari na karshe na gwajin ENABLE-2 mai mahimmanci na Mataki na 3. Suna kan hanya don fara ENABLE-2 kafin karshen shekara ta 2026. Tana da ingantacciyar takardar ma'auni tare da dala miliyan 884 a cikin tsabar kudi, da abubuwan da suka yi daidai da tsabar kudi, da kuma hannayen jari da ake sayarwa a kasuwa, wanda ake tsammanin zai samar da isasshen kuɗi har zuwa shekarar 2030...

Karanta tushen
Likitanci da magungunaAyyukan da ake kan yi da ci gabaPR Newswire (Clinical Trials)

Skyhawk Therapeutics Ta Sanar da Ba wa Marasa Lafiya na Farko a Amurka Magani a cikin Binciken Mahimmanci na FALCON-HD da ke Nazarin SKY-0515 a Cutar Huntington

An riga an ba marasa lafiya adadin alluran SKY-0515 sama da 50,000. BOSTON, Nuwamba 5, 2026 /PRNewswire/ -- Skyhawk Therapeutics, Inc., wani kamfanin fasahar kere-kere na matakin asibiti wanda ke haɓaka sabbin magungunan ƙananan ƙwayoyin cuta da aka tsara don daidaita hanyoyin RNA, a yau ya sanar da cewa na farko a Amurka...

Karanta tushen

Bayanan hukuma

Ƙa'idoji da sanarwa da aka tabbatar daga hukumomin gwamnati, masu kula da ƙa'ida da jaridun hukuma.

Likitanci da magungunaHealth Sciences Authority (Singapore)SG

HSA ta janye AGELMIN TABLET 10 mg saboda matsalar inganci

Hukumar Kula da Kimiyyar Lafiya (Health Sciences Authority) ta ba da sanarwar janye maganin AGELMIN TABLET 10 mg a matakin sayarwa na Class 2, lamba ta 231871, wanda kamfanin PHARMAKOE PTE LTD ya ƙera. An fara janye maganin ne saboda sakamakon gwajin narkarwa da bai cika ka'ida ba wanda aka gano a ƙarƙashin shirin kula da ingancin samfur.

Karanta tushen
Likitanci da magungunaWHO

WHO Ta Ƙara Sunayen Allurar Rigakafin Ebola Biyu Cikin Gwajin Tumaini a DRC

WHO ta ba da shawarar ƙara ChAdOx1 da mRNA-1469 na kamfanin Moderna cikin gwajin asibiti na Tumaini a Jamhuriyar Dimokaradiyyar Kwango. Ana kimanta waɗannan alluran rigakafin ne a kan Bundibugyo virus disease (Ebola), wanda ke nuna karo na farko da aka yi niyyar kai hari ga wannan takamaiman nau'in a cikin wannan binciken da ke ci gaba.

Karanta tushen

Karanta kowane bayani da yarenka

Wannan shafi yana nuna sabbin abubuwa uku ne kawai a kowane fanni. Mambobi na ganin kowane bayani a cikin fannin, a harsuna 109, tare da injinan bincike da ke aiki a kansu.

Karanta duka kan $9

Babu buƙatar shigarwa daga kantin manhajoji. Ana iya soke shi kowane lokaci.

Sabbin abubuwa a kowane fanni

Lafiyar dabbobiTsaron abinci da nomaKimiyya da fasahaTsaron yanar gizo da ƙa'idojin bayanaiMakamashi da yanayiMallakar hankali da haƙƙin ƙirƙiraKasuwanci da sarkar samarwaSanarwar kamfanoni da haɗin gwiwa

Kowane abu yana da haɗi zuwa cibiyar da ta wallafa shi. Ba a sake rubuta komai ba tare da tushensa ba.

FarashiTambayoyin da ake yawan yi